MEDICURE INC
MEDICURE INC is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $7.6M market cap.
Most recent earnings call: Q4 FY24 on Apr 30, 2025.
8 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks MCUJF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MCUJF.
$ curl https://api.spokenalpha.com/v1/companies/MCUJFFAQ
Spoken Alpha indexes MCUJF's earnings call transcripts at https://spokenalpha.com/companies/MCUJF. Each call links to attributed speakers and parsed analyst Q&A. MEDICURE INC's own investor relations page is at https://www.medicure.com/investors.
MEDICURE INC (MCUJF) held its most recent earnings call on 2025-04-30, covering fiscal Q4 2024.
MEDICURE INC (MCUJF) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2024 | $4.49 | $3.69 | +21.8% | -6.0% | -8.3% |
| Q4 FY2024 | $4.91 | $3.89 | +26.2% | +3.2% | +1.6% |
| Q3 FY2024 | $4.94 | $3.98 | +24.2% | -3.9% | -4.5% |
| Q2 FY2024 | $4.55 | $3.99 | +14.1% | -0.4% | -2.9% |
| Q1 FY2023 | $4.59 | $3.89 | +17.9% | +4.4% | +4.4% |
| Q4 FY2023 |
| $5.14 |
| $3.99 |
| +28.7% |
| -2.1% |
| -1.8% |
| Q3 FY2023 | $4.81 | $4.04 | +19.1% | +4.8% | +7.5% |
| Q2 FY2023 | $4.63 | $3.80 | +21.8% | +0.2% | +1.9% |
| Q1 FY2022 | $5.04 | $3.95 | +27.5% | -5.9% | -6.9% |
| Q4 FY2022 | $4.87 | $4.10 | +18.7% | +4.1% | +5.4% |